November 18, 2026 · The Journal of arthroplasty · DOI: 10.1016/j.arth.2026.11.072

Xa Inhibitors Are Associated with an Increased Risk of Manipulation after Primary Total Knee Arthroplasty Compared to Aspirin in a Contemporary Cohort.

Listen to this summary

This study asked whether factor Xa inhibitors (rivaroxaban, apixaban) used for VTE prophylaxis after primary total knee arthroplasty increase the risk of manipulation under anesthesia (MUA) compared with aspirin, and how the two Xa inhibitors compare. Using a database of 435,789 unilateral primary TKAs from 2021 to 2023, the authors found MUA within 90 days occurred more often with Xa inhibitors than aspirin (3.9% vs 2.8%), with an adjusted odds ratio of 1.60 for Xa inhibitors. Rivaroxaban had similar unadjusted MUA rates to apixaban but lower adjusted odds (OR 0.89), suggesting Xa inhibitors are associated with higher MUA risk, though this is an observational association.

Andrew S McGee, Alexander J Baur, Paul M Werth, Michael A Caprise, Stephen T Duncan, David C Landy

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play